Helus Pharma Inc.
General ticker "HELP" information:
- Sector: Health Care
- Industry: Medical - Pharmaceuticals
- Capitalization: $391.5M (TTM average)
Helus Pharma Inc. follows the US Stock Market performance with the rate: 42.9%.
Estimated limits based on current volatility of 5.8%: low 8.27$, high 9.30$
Factors to consider:
- Earnings expected soon, date: 2026-11-12 bmo
Short-term HELP quotes
Long-term HELP plot
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | CA$0.25MM | CA$0.00MM | CA$0.47MM |
| Operating Expenses | CA$51.77MM | CA$78.84MM | CA$143.62MM |
| Operating Income | CA$-51.52MM | CA$-78.84MM | CA$-143.15MM |
| Non-Operating Income | CA$3.78MM | CA$0.76MM | CA$29.54MM |
| R&D Expense | CA$25.49MM | CA$32.36MM | CA$54.91MM |
| Income(Loss) | CA$-47.74MM | CA$-78.08MM | CA$-113.61MM |
| Taxes | CA$-0.25MM | CA$0.00MM | CA$-0.47MM |
| Net Income(Loss)* | CA$-47.49MM | CA$-78.08MM | CA$-113.14MM |
| Stockholders Equity | CA$48.23MM | CA$291.93MM | CA$237.20MM |
| Assets | CA$53.90MM | CA$302.02MM | CA$258.62MM |
| Operating Cash Flow | CA$-47.43MM | CA$-68.91MM | CA$-101.30MM |
| Capital expenditure | CA$3.31MM | CA$0.71MM | CA$1.97MM |
| Investing Cash Flow | CA$-3.31MM | CA$6.92MM | CA$-1.97MM |
| Financing Cash Flow | CA$13.56MM | CA$254.51MM | CA$20.20MM |
| Earnings Per Share** | CA$-9.73 | CA$-3.90 | CA$-5.59 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.